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Abstract
Background: In addition to immune cells, many other cell types are known to produce cytokines.
Cultured normal mouse gallbladder epithelial cells, used as a model system for gallbladder
epithelium, were examined for their ability to express the mRNA of various cytokines and
chemokines in response to bacterial lipopolysaccharide. The synthesis and secretion of the tumor
necrosis factor- (TNF-) protein by these cells was also measured.
Results:  Untreated mouse gallbladder cells expressed mRNA for TNF-, RANTES, and
macrophage inflammatory protein-2 (MIP-2). Upon treatment with lipopolysaccharide, these cells
now produced mRNA for Interleukin-1 (IL-1), IL-6, monocyte chemoattractant protein-1 (MCP-
1), and showed increased expression of TNF- and MIP-2 mRNA. Untreated mouse gallbladder
cells did not synthesize TNF- protein; however, they did synthesize and secrete TNF- upon
treatment with lipopolysaccharide.
Methods: Cells were treated with lipopolysaccharides from 3 strains of bacteria. Qualitative and
semi-quantitative RT-PCR, using cytokine or chemokine-specific primers, was used to measure
mRNA levels of TNF, IL-1, IL-6, IL-10, KC, RANTES, MCP-1, and MIP-2. TNF- protein was
measured by immunoassays.
Conclusion:  This research demonstrates that gallbladder epithelial cells in response to
lipopolysaccharide exposure can alter their cytokine and chemokine RNA expression pattern and
can synthesize and secrete TNF protein. This suggests a mechanism whereby gallbladder epithelial
cells in vivo may mediate gallbladder secretory function, inflammation and diseases in an autocrine/
paracrine fashion by producing and secreting cytokines and/or chemokines during sepsis.
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Background
The biliary system is more than a passive conduit trans-
porting bile from the liver to the intestines. Hepatic bile is
actively modified by the epithelial cells that line the bile
ducts and gallbladder. Biliary epithelial function is par-
tially under the control of secretin and vasoactive intesti-
nal peptide [1]. Other extracellular agonists that influence
biliary function include neuropeptides [2,3], ATP [4,5],
and bile salts [6]. In addition to the well-documented role
that cytokines play in the immune response and inflam-
mation [7,8], cytokines also modify the functioning of ep-
ithelial cells. For instance, tumor necrosis factor- (TNF-
) can modify intracellular signal transduction and regu-
late ionic channel activities in various epithelial cells [9].
A few studies have shown that cytokines can alter biliary
epithelial cell function [10,11].
Biliary epithelial cells are capable of producing a great va-
riety of physiologically active compounds. For example, it
has been shown that biliary epithelial cells synthesize ni-
tric oxide, a strong vasodilator [12], and endothelin-1
[13], a potent vasoconstrictor. Various cytokines are also
produced by biliary epithelial cells [14]. As biliary epithe-
lial cells are capable of both producing and responding to
cytokines, these cells may use cytokines for the autocrine/
paracrine regulation of their own function as well as that
of other cells.
Bile in the biliary ducts and the gallbladder often contains
bacteria and the bacterial product lipopolysaccharide
(LPS). This may be due to ascending infection from the in-
testine or descending infection via portal venous blood
[15,16]. Bacterial infection usually leads to activation of
the immune system followed by inflammation. While in-
flammation is an important element in the defense
against infection, it can also contribute to cholestatic bil-
iary diseases and cholelithiasis. Therefore, the control of
the immune and inflammatory response of biliary tissue
to bacteria is important in determining disease progres-
sion. While the biliary epithelium can act as a physical
barrier to limit bacterial infection of the underlying tissue
[16], its physiological response to bacteria and bacterial
products is not well characterized. Like pulmonary and in-
testinal epithelial cells, biliary epithelial cells might re-
spond to bacteria in bile by producing cytokines and other
factors. To test this hypothesis, we used cultured normal
mouse gallbladder epithelial cells (MGBE) as an in vitro
model system to examine the ability of gallbladder epithe-
lium to produce mRNA for various cytokines and chem-
okines. The synthesis and secretion of TNF- protein was
also measured. These cells demonstrated distinct changes
in their cytokine and chemokine mRNA expression profile
and TNF- protein production in response to LPS.
Methods
Materials
Analytical grade chemicals and tissue culture supplies
were obtained from Sigma Chemical Co. (St. Louis, MO),
except where noted. Vitrogen (bovine dermal collagen)
was purchased from Collagen Corp. (Palo Alto, CA). Tran-
swell inserts (24 mm diameter, 3 m pore size) were pur-
chased from Corning Corp. (Acton, MA).
Cell culture
MGBE were grown as previously described [17]. In brief,
MGBE were grown on Vitrogen-coated Transwell inserts
suspended above human gallbladder myo-fibroblast feed-
er cells. The cells were fed with Eagle's minimum essential
medium containing 10% fetal bovine serum, 2 mM L-
glutamine, 20 mM HEPES, 100 IU/mL penicillin, 100 g/
mL streptomycin, plus Insulin-Transferrin-Sodium Se-
lenite Media Supplement, MEM-vitamins, and MEM-non-
essential amino acid solution (Sigma Chemical Co.).
Confluent MGBE have well-differentiated morphology
and high transepithelial electrical resistance (163 /cm2)
[17]. Prior to each experiment, Transwell inserts with con-
fluent MGBE were transferred to new plates without feed-
er cells.
Table 1: Murine specific primer sequences used in PCR
mRNA Forward Primer Reverse Primer Expected product
 size (bp)
GenBank accession
 number
IL-1 5'-gtgtgatgttcccattagacagc 5'-tgagaggtgctgatgtaccagtt 383
IL-6 5'-gaaaatctgctctggtcttctgg 5'-ttttctgaccacagtgaggaatg 357 M26744
IL-10 5'-tcagtcaagtgaagactttctttc 5'-gcagttgatgaagatgtcaaactc 358 X60675
TNF 5'-tgaacttcggggtgatcggtc 5'-agccttgtcccttgaagagaac 295 X66539
KC (CXCL1) 5'-ttgaaggtgatgccgccag 5'-cccagactctcatctctcc 205
RANTES (CCL5) 5'-ccccatatggctcggacacca 5'-ctagctcatctccaaatagttgat 205
MCP-1 (CCL2) 5'-cactatgcaggtctctgtcacg 5'-gatctcacttggttctggtcca 294 M57441
MIP-2 (CXCL2) 5'-cagtgagctgcgctgtccaatg 5'-cagttagccttgcctttgttcag 210 X65647
GAPDH 5'-atgtcagatccacaacggatacat 5'-actccctcaagattgtcagcaat 307
ARP 5'-gttgaacatctcccccttctc 5'-atgtcctcatcggattcctcc 402 Z29530BMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/23
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RT-PCR assay of cytokine and chemokine mRNA
Confluent MGBE were fed serum-free medium. Cells were
treated with LPS from E. coli (serotype 0111:B4) or Pseu-
domonas aeruginosa (serotype 10) at 100 g/mL, added
to the apical compartment of the insert. After two hours,
the cells were harvested by trypsinization, and total RNA
was extracted using TRIzol reagent (Gibco BRL, Gaithers-
burg, MD). Five g of total RNA was reverse-transcribed
according to the manufacturer's protocol (Superscript II
Preamplification System, Gibco BRL) using oligo (dT) as
primer. cDNA prepared from 0.5 g RNA was subjected to
PCR using murine gene-specific primers for 8 different cy-
tokines and chemokines (Table 1) as previously detailed
[18]. All of the primer pairs spanned at least one intron in
the corresponding genomic DNA. Positive RNA controls
were performed previously to confirm specificity of prim-
er pairs (data not shown). Negative controls were per-
formed by omitting the RT step or the cDNA template
from PCR amplification. For qualitative PCR, target se-
quences were amplified at 56C for 25 cycles; for semi-
quantitative PCR, target sequences for TNF-, IL-1, and
MIP-2 (CXCL2) were amplified at 56C between 22 and
32 cycles in order to yield visible products within the lin-
ear amplification range. PCR products were separated by
electrophoresis on a 2% agarose gel and stained with
ethidium bromide. All RT-PCR bands at the expected size
were also directly sequenced to confirm their identity.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or
acidic ribosomal phosphoprotein (ARP) were used as in-
ternal controls.
TNF- Immunoassay
Confluent MGBE were fed serum-free medium, with or
without LPS added to the apical side (LPS concentration =
2 or 100 g/mL). Medium from the apical and basolateral
compartment was collected separately at measured inter-
vals and immediately frozen at -70C. The cells were lysed
with 1% NP-40 buffer (150 mM NaCl, 50 mM Tris, pH
8.0) containing 100 g/mL phenylmethylsulfonyl fluo-
ride and 1 g/mL aprotinin, sonicated for 30 seconds,
then frozen. TNF- was measured in cell lysate and undi-
luted medium using the Mouse TNF- Immunoassay Kit
from R&D Systems (Minneapolis, MN). Statistical analy-
sis on the TNF- immunoassay data was performed using
Student's t-test. Cell viability was assessed by measuring
lactate dehydrogenase release into the medium, as previ-
ously described [6]. Changes in transepithelial permeabil-
ity was measured using 3H-mannitol as a small molecular
weight probe. Tritiated mannitol (2 Ci) with cold man-
nitol (0.15 mM) was added to the apical medium and
samples of the basolateral medium harvested and count-
ed at 1, 2, 4, and 24 hours after LPS treatment.
Results
RT-PCR
Using cytokine/chemokine-specific primers with RT-PCR,
untreated MGBE showed distinct bands representing
mRNA of TNF-, RANTES (Regulated on activation, nor-
mal T cell expressed and secreted) (CCL5), and macro-
phage inflammatory protein-2 (MIP-2/CXCL2) (Figure
1). Upon apical treatment with LPS from E. coli for two
hours, these cells additionally produced mRNA for inter-
leukin-1 (IL-1), IL-6, and monocyte chemoattractant
protein-1 (MCP-1/CCL2). There was no detectable expres-
sion of IL-10 or KC (murine GRO-/CXCL1) mRNA be-
fore or after LPS treatment. Semi-quantitative RT-PCR
using specific primers for TNF-, MIP-2 (CXCL2) and IL-
1 showed that LPS treatment caused the amount of TNF-
 mRNA to slightly increase compared to the already
abundant levels found in untreated cells (figure 2 and 3).
In contrast, there was a substantial increase in the expres-
sion of MIP-2 (CXCL2) mRNA and IL-1 mRNA following
LPS treatment compared to control. Similar responses
were seen when the cells were treated with LPS from P. aer-
uginosa (Figure 2 and 3). All visualized PCR product bands
were of the expected size and nucleotide sequence con-
firming proper identification. Although the RANTES
(CCL5) sample had extra bands of unknown origin, the
band at the expected size of 205 bp had a nucleotide se-
quence that matched RANTES.
TNF- Immunoassay
The immunoassay experiments showed no detectable
TNF- in untreated MGBE or their surrounding media af-
ter 5 hours of incubation (limit of detection = 5.1 pg/mL).
In contrast, following treatment with 100 g/mL E. coli
Figure 1
RT-PCR for cytokine mRNAs Treated MGBE were
exposed to 100 g/mL E. coli LPS on the apical surface for
two hours. GAPDH was used as an internal control to stand-
ardize starting mRNA quantity. This experiment was
repeated twice with equivalent results.BMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/23
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LPS the concentration of TNF- protein in the cells was
33.6 pg per 106 cells in one hour (Figure 4). Intracellular
TNF- concentration reached a peak two hours after LPS
treatment with a subsequent decrease by five hours. After
two and five hours of LPS treatment, there was measurable
release of TNF- into the media of both the apical and ba-
solateral compartments (figure 5). Three different species
of LPS (E. coli, P. aeruginosa, and Klebsiella pneumoniae)
stimulated TNF- release in a similar fashion (figure 6).
Treatment with 2 g/mL E. coli LPS showed comparable
results. None of the treatments increased lactate dehydro-
genase in the medium compared with controls showing
Figure 2
Semi-quantitative RT-PCR Semi-quantitative RT-PCR
products from cytokine mRNA using MIP-2, TNF-, and IL-
1 specific primers. C is untreated control cells. Treated
cells were exposed to 100 g/mL LPS from either E. coli or P.
aeruginosa on the apical surface for two hours. ARP was used
as an internal control to standardize starting mRNA quantity.
PCR cycle number used was between 22 for ARP and 31 for
TNF-.
Figure 3
Densitometry analysis of semi-quantitative RT-PCR
results Densitometry of PCR bands for MIP-2, TNF-, and
IL-1 (from figure 2) based on % of ARP control bands using
ImageJ Program (Version 1.20s).
Figure 4
Intracellular TNF- following LPS treatment Intracel-
lular TNF- concentration of MGBE over time following api-
cal exposure to 100 g/mL  E. coli LPS was measured by
immunoassay. Values are the means  standard error of
results from three to four assays.
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that the LPS treatments did not alter epithelial cell integri-
ty (data not shown). LPS treatment also had no effect on
the transepithelial permeability of these cells for up to 24
hours as measured by 3H-mannitol diffusion experiments
when compared to controls (data not shown).
Discussion
Bacteria are found in the bile of the gallbladder and bile
ducts [15,16], the presence of which may have relevance
to clinical diseases such as stone formation [19–21], pri-
mary sclerosing cholangitis [22], and cholestasis [23,24].
Direct exposure of sub-epithelial tissue to LPS from gram-
negative bacteria causes release of cytokines by resident
leukocytes and activation of macrophages [25]. The bil-
iary fluid of patients with cholangitis has increased con-
centrations of the inflammatory cytokines TNF- and IL-6
suggesting that bacterial infection leads to an increase in
cytokines released into the bile [26]. Adding LPS to the
bile of guinea pig gallbladders in vivo led to increased IL-1
concentration in the bile [27]. What role biliary epithelial
cells play in the response to bacteria in bile is not known.
While most cytokine research has focused on cells of the
immune system, other cell types produce cytokines in-
cluding the epithelial cells of the lung [28,29], retina [30],
and intestines [31,32]. Among the few studies involving
the biliary system, it was demonstrated that cultured hu-
man intrahepatic duct epithelial cells produce functional
IL-8 and MCP-1 (CCL2) [14,33]. Isolated human intrahe-
patic epithelial ducts expressed immunoreactive IL-6
when treated with IL-1 or phorbal myristate acetate [34].
Intracellular TNF- mRNA and protein was detected in in-
trahepatic biliary duct cells in tissue sections [35], but not
in cultured intrahepatic epithelial cells; therefore, there
was no clear demonstration that biliary epithelium se-
cretes TNF-. Little research has focused on the ability of
the epithelial cells of the extrahepatic biliary system to
produce cytokines or chemokines.
As described in this paper, MGBE were used as an in vitro
model system of gallbladder epithelium to measure the
endogenous production of cytokines and chemokines by
extrahepatic biliary epithelial cells. These cultured cells
consist exclusively of normal, non-neoplastic epithelial
cells [17], without other cell types such as leukocytes ordi-
narily found in biliary tissues. The experiments showed
that unstimulated MGBE express mRNA for TNF-, MIP-
2, and RANTES (CCL5). After treating the apical surface of
the cells with LPS, the mRNA levels for TNF- and MIP-2
(CXCL2) increased, while mRNA for IL-1, IL-6, and
MCP-1 (CCL2) appeared for the first time. Therefore, cy-
tokines (TNF-, IL-1, and IL-6), a C-C type chemokine
(MCP-1/CCL2), and a C-X-C type chemokine (MIP-2/
CXCL2) are all up regulated at the RNA level by bacterial
product interaction with the epithelial cells. The effects of
LPS treatment for two hours on cytokine and chemokine
mRNA expression clearly suggests that biliary epithelial
Figure 5
TNF- secretion into medium Release of TNF- into
the apical and basolateral medium by cultured MGBE
exposed to 100 g/mL E. coli LPS over time. TNF- secretion
was calculated as the total pg amount of TNF- present in
the apical or basolateral medium. Values are the means of
triplicates  standard error from a single assay. This assay
was repeated twice more with similar results. Statistical dif-
ferences between the concentration of TNF- in the basal
and apical medium were measured by paired Student's t-test
(* = p < 0.01).
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Figure 6
Effects of LPS from different bacteria on TNF-
secretion Release of TNF- into the apical and basolateral
medium by cultured MGBE exposed to 100 g/mL LPS from
various bacteria for two hours. TNF- was measured by
immunoassay and calculated as the total pg present in the
apical and basolateral medium. Each treatment was done in
triplicate and assay repeated twice more with E. coli LPS and
once more with P. aeruginosa and K. pneumoniae LPS. Values
represent the mean of each treatment (n = 9 for E. coli LPS
and n = 6 for P. aeruginosa and K. pneumoniae LPS)  standard
error. There was a statistical difference between the amount
of TNF- in the basal versus apical medium as measured by
paired Student's t-test (* = p < 0.01).
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cells can modify their own cytokine and chemokine pro-
duction after bacterial challenge at the mRNA level. As
with all in vitro cell systems there is the possibility that the
cells in culture may have phenotypic changes to their cy-
tokine profile compared to in vivo cells. In other parame-
ters tested (i.e., morphology, mucin secretion, etc.), these
cells retain the normal phenotype of cells in vivo.
Measurements of TNF- protein showed that MGBE syn-
thesize and secrete TNF- when exposed to LPS, while un-
treated cells do not. This demonstrates that gallbladder
epithelial cells themselves secrete a cytokine in response
to bacterial products. The results from RT-PCR (showing a
relatively high TNF- mRNA expression levels in untreat-
ed cells which is only slightly increased by LPS treatment)
along with the immunoassay results suggest that TNF-
mRNA is constantly present in these cells, but is not trans-
lated into protein until certain triggers are provided. This
is consistent with the post-transcriptional regulation of
TNF- observed in other cells [36]. In contrast, the mRNA
of other factors, such as IL-1, IL-6, and MCP-1 (CCL2)
are not synthesized until the cells are stimulated, suggest-
ing that their production is under transcriptional control.
The protein expression of these other cytokines and chem-
okines along with the precise nature of the interaction be-
tween LPS and cell surface receptors warrants further
study.
While the exact role that gallbladder epithelial cells play
in inflammatory and infectious diseases has yet to be de-
termined, our research supports the hypothesis that gall-
bladder epithelium have some innate cytokine-producing
capabilities in response to the presence of bacteria on
their apical surface. The accumulation of TNF- in the
gallbladder bile of patients with cholangitis may be due in
part to the apical release of TNF- by biliary epithelial
cells. In contrast, basolateral secretion of TNF- could
lead to a focal accumulation of TNF- in the sub-mucosa
of biliary tissue. Sufficient cytokine secretion could then
stimulate the leukocytes in the sub-epithelial tissue, lead-
ing to inflammation of the tissue, without the need for the
bacteria to pass through the epithelial barrier. The produc-
tion of cytokines by gallbladder epithelial cells following
LPS exposure demonstrates that biliary epithelial cells
may be an active partner with the immune system in the
detection of and defense against bacteria in bile.
During sepsis, biliary epithelial cells could mediate biliary
secretory function through cytokine and chemokine pro-
duction. Dog gallbladder epithelial cells demonstrated in-
creased mucin secretion following TNF- treatment [10].
In addition, exogenous TNF- altered the absorptive
properties of cultured human gallbladder epithelial cells
[37]. It is therefore reasonable to suggest that TNF- pro-
duced by gallbladder epithelial cells in response to LPS
could affect cellular function in an autocrine manner.
Since mucin secretion and gallbladder transport proper-
ties play vital roles in cholelithiasis, changes in these pa-
rameters caused by endogenous cytokines and
chemokines may promote stone formation. Epithelial-de-
rived cytokines and chemokines also may alter biliary
function leading to cholestasis.
Conclusions
Gallbladder epithelial cells demonstrated distinct patterns
of expression of mRNA for various cytokines and chemok-
ines, and responded to treatment with LPS by altering
their expression of certain cytokine and chemokine RNA
and increasing TNF- protein synthesis and secretion. The
ability of biliary epithelial cell to control endogenous cy-
tokine and chemokine production has important implica-
tions for biliary inflammation and diseases, such as
cholangitis, cholestasis, and cholelithiasis.
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